Barth T, et al. - A total of 54 individuals with unilateral choroidal rupture following ocular trauma diagnosed between 2000 and 2016 were retrospectively assessed in order to report a large case series of people with choroidal neovascularizations (CNV) secondary to choroidal rupture following ocular trauma receiving intravitreal anti-VEGF (vascular endothelial growth factor) injections. This was, to date, the largest case series of traumatic CNV membranes treated with anti-VEGF injections with a mean follow-up period of 5 years. For secondary CNV following choroidal rupture, intravitreal anti-VEGF therapy appeared to be safe and efficient. Thus, in comparison with exudative age-related macular degeneration, fewer injections are required to control the disease.